I read the article different from an oops. They are saying that they want to use genetic information to make the drugs more specific to individuals -- then they can charge more money and the drugs will be difficult for generic producers and Canadian exporters.
On Mon, Dec 08, 2003 at 10:47:09AM -0800, Eubulides wrote: > http://news.independent.co.uk/world/science_medical/story.jsp?story=471139 > Glaxo chief: Our drugs do not work on most patients > By Steve Connor, Science Editor > 08 December 2003 > > > A senior executive with Britain's biggest drugs company has admitted that > most prescription medicines do not work on most people who take them. > > Allen Roses, worldwide vice-president of genetics at GlaxoSmithKline > (GSK), said fewer than half of the patients prescribed some of the most > expensive drugs actually derived any benefit from them. > -- Michael Perelman Economics Department California State University Chico, CA 95929 Tel. 530-898-5321 E-Mail [EMAIL PROTECTED]
